Novel Therapeutic Targets for Treatment of Neurodegeneration

Tue19  Oct04:30pm(30 mins)
Hall 1C
 Paul Brennan


New treatments for common neurodegenerative conditions such as Alzheimer’s and Parkinson’s Disease are urgently needed for our aging society. At the Alzheimer’s Research UK Oxford Drug Discovery Institute we are pursuing early drug discovery efforts on novel targets in neuroinflammatory and sub-cellular organelle dysfunction pathways. In addition to an introduction to our target evaluation and selection strategy, our latest efforts to discovery CNS-penetrant leads for the NLRP3 inflammasome will be presented.
To view the video assoicated with this lecture click here

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021